Navigation Links
Joseph J. LaRosa Joins Nycomed US Inc.
Date:11/10/2010

MELVILLE, N.Y., Nov. 10, 2010 /PRNewswire/ -- Nycomed US Inc. announced today the appointment of Joseph J. LaRosa as its new Senior Vice President and General Counsel, reporting to Steve Andrzejewski, CEO of Nycomed US.  Joe will be the chief legal advisor of the company and oversee all of the company's legal and intellectual property matters.  In addition, he will also be responsible for the company's compliance functions.  

Joe was Vice President, Legal Affairs at Schering-Plough Corporation, where he served as a corporate officer and a member of the operations management team.  In over 15 years with that company he led several critical legal functions including international, US health care and managed markets, marketing and sales, commercial law and M&A /licensing.  He also served as corporate secretary to the board and headed the securities and governance group.  Joe's experience in compliance includes serving as Vice President of Global Compliance and Legal Affairs at Avon Products, Inc., where he was that company's first global chief compliance officer.  Earlier, Joe practiced law with New York law firms.

Joe holds a law degree from New York University School of Law and a BA in Psychology and Political Science from New York University.

"I am delighted to welcome Joe to Nycomed US.  He is a seasoned, business savvy lawyer and an important addition to my Executive Leadership Team," says Steve Andrzejewski, CEO of Nycomed US.  "Joe's broad industry and legal experience will provide us with the infrastructure to advance our business goals and commitment to compliance and business integrity."

About Nycomed US

Nycomed US Inc. is a subsidiary of Nycomed and operates two divisions in the United States focused on specialty pharmaceuticals in dermatology.  Founded in 1849, Fougera is a division of Nycomed US Inc. and is the leading manufacturer and distributor of a wide range of topical products.  The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.  For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at www.fougera.com.  Information on PharmaDerm products can be found online at www.pharmaderm.com.  More information is also available at www.nycomedus.com.


'/>"/>
SOURCE Nycomed US Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
2. Speedus Engages Morgan Joseph to Evaluate Strategic Alternatives for Zargis Subsidiary
3. Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation
4. PDI Mourns Death of Board Member Dr. Joseph T. Curti
5. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
6. The Womens Heart Foundation Presents the Womens Heart Advocate Award for Medicine and Science to Multifunction CardioGram(TM) Inventor Dr. Joseph T. Shen
7. MoleSafe USA Expands Services to Leading Cancer Facilities at St. Josephs/Candler and CentraState Medical Center
8. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
9. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
10. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology:
(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):